Table 2.
Year | Author | N | Indication | Initial ERCP | Techniques | Technical success | Clinical success | Complication |
---|---|---|---|---|---|---|---|---|
1996 | Wiersema et al. [7] | 10 | B | Both | D | 7/10 (70%) | n/a | 1/10 (10%) |
2005 | Püspök et al. [19] | 5 | M | Sb | T | 5/5 (100%) | 5/5 (100%) | No |
2006 | Kahaleh et al. [28] | 10 | Both | Sb | 8 R; 2 T | 9/10 (90%) | 9/10 (90%) | 3/9 (33%) |
2008 | Yamao et al. [29] | 5 | M | Sb | T | 5/5 (100%) | 5/5 (100%) | 1/5 (20%) |
2008 | Tarantino et al. [30] | 9 | Both | Sb | 4 T; 4 R; 1 D | 9/9 (100%) | 9/9 (100%) | No |
2009 | Maranki et al. [12] | 14 | Both | Sb (mostly) | 8 R; 4 T | 12/14 (86%) | 12/12 (100%) | 3/14 (21%) |
2009 | Brauer et al. [13] | 12 | Both | Sb | 4 R; 4 T; 3 D | 11/12 (92%) | 11/11 (100%) | 2/12 (16.7%) |
2009 | Horaguchi et al. [14] | 8 | M | Sb | T | 8/8 (100%) | 8/8 (100%) | 1/8 (12.5%) |
2010 | Kim et al. [10] | 15 | Both | Sm (mostly) | R | 12/15 (80%) | 11/12 (91.7%) | 2/15 (13.3%) |
2010 | Iwamuro et al. [27] | 7 | M | Sb | T | 7/7 (100%) | 7/7 (100%) | 2/7 (28%) |
2011 | Siddiqui et al. [31] | 8 | M | Sb | T | 8/8 (100%) | 8/8 (100%) | 2/8 (25%) |
2011 | Komaki et al. [32] | 15 | M | n/a | 14 T; 1 R | 15/15 (100%) | 15/15 (100%) | 7/15 (47%) |
2011 | Hara et al. [33] | 18 | M | n/a | T | 17/18 (94%) | 17/17 (100%) | 3/18 (17%) |
2011 | Park do et al. [11] | 26 | Both | Sm | T | 24/26 (92%) | 22/24 (92%) | 5/26 (19%) |
2011 | Ramírez-Luna et al. [34] | 9 | M | Sb | T | 8/9 (89%) | 8/8 (100%) | 1/9 (11%) |
2011 | Fabbri et al. [35] | 16 | M | Sm | 13 T; 3 R | 12/16 (75%) | 12/12 (100%) | 1/16 (6.25%) |
2012 | Dhir et al. [26] | 58 | Both | Sm | R | 57/58 (98.3%) | 57/57 (100%) | 2/58 (3.4%) |
2012 | Iwashita et al. [36] | 31 | Both | Sm | R | 25/31 (81%) | 25/25 (100%) | 4//31 (13%) |
2012 | Kim et al. [20] | 9 | M | Sb | T | 9/9 (100%) | 9/9 (100%) | 3/9 (33%) |
2012 | Shah* et al. [9] | 70 | Both | Sm | 46 R; 20 A (or T); 2 D | 60/70 (85.7%) | n/a | 6/70 (8.5%) |
2012 | Maluf-Filho et al. [37] | 5 | M | Sm | T | 5/5 (100%) | 3/5 (60%) | 2/5 (40%) |
| ||||||||
Total | 360 | 178 R; 141 T; 20 A; 16 D | 325/360 (90%) | 254/258 (98%) | 51/360 (14%) |
EUS-CP: endoscopic-ultrasound-guided cholangiopancreatography, N: number of patients, B: benign, M: malignant, Sb: subsequent day, Sm: same day/session, D: ductography, T: transluminal, R: rendezvous, A: antegrade, n/a: not applicable/mentioned. *The biliary tree was accessed at extra- as well as intrahepatic levels. However, the exact puncture site was not specified in the paper.